Trial Profile
Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacteraemia; Endocarditis; Gram-positive infections
- Focus Adverse reactions
- 03 Mar 2011 New trial record